Report

Use of the Quinoline anti-malarial drugs Mefloquine and Tafenoquine in the Australian Defence Force

4 December 2018

© Commonwealth of Australia 2018
ISBN 978-1-76010-864-9

View the report as a single document - (PDF 1094KB)


View the report as separate downloadable parts:

Committee Membership (PDF 25KB)
ASSISTANCE CONTACT INFORMATION (PDF 10KB)
Recommendations (PDF 31KB)
Executive Summary (PDF 32KB)

The disagreement over the cause of symptoms
The symptoms are real
Conduct of the studies
Moving forward

Chapter 1 - Introduction (PDF 115KB)

Referral
Conduct of the inquiry
Acknowledgement
Structure of the report
Key terminology, concepts and medications
Other relevant Australian committee inquiries
Other relevant inquiries
Other governments and organisations

Chapter 2 - The causes of symptoms (PDF 295KB)

Introduction
Disagreement over the cause of symptoms
Possible side-effects
TGA database of adverse events
Related medical inquiries
Searching for an explanation
Conclusion

Chapter 3 - Antimalarial drug trials involving the ADF (PDF 248KB)

Consenting to participate in research
ADF antimalarial prescribing policies and practices
Details of the antimalarial drug trials
The consent process during the trials 
Screening processes
Response to adverse events
Follow up with trial participants

Chapter 4 - Assistance and support for veterans (PDF 235KB)

Introduction
Summary of Government actions to date
Veterans' experiences with accessing assistance
Barriers to accessing assistance
What assistance and support are veterans seeking?
How can the concerns raised by veterans be addressed?

Chapter 5 - Conclusions and Recommendations (PDF 79KB)

Medical concerns
ADF participation in medical research
Assistance and support for veterans
Ensuring access to additional support and assistance

Appendix 1 - Submissions (PDF 14KB)
Appendix 2 - Tabled documents, Additional information, Answers to questions on notice (PDF 9KB)

Tabled documents
Additional information
Answers to questions on notice

Appendix 3 - Public hearings and witnesses (PDF 16KB)

Thursday 30 August 2018, Brisbane Queensland
Friday 31 August 2018, Townsville Queensland
Thursday 11 October 2018, Canberra Australian Capital Territory
Monday 15 October 2018, Canberra Australian Capital Territory
Monday 5 November 2018, Melbourne Victoria
Thursday 8 November 2018, Canberra Australian Capital Territory

Committee Secretariat contact:

Foreign Affairs, Defence and Trade Committee
Department of the Senate
PO Box 6100
Parliament House
Canberra ACT 2600

Phone: +61 2 6277 3535
Fax: +61 2 6277 5818
fadt.sen@aph.gov.au

Top